Immunotherapy could be used to treat depression, early trial suggests
UK scientists find tocilizumab, used for rheumatoid arthritis, may help antidepressant-resistant patientsImmunotherapy could be used to treat depression among patients who have not responded to conventional antidepressants, according to the results of an early clinical trial.Researchers at the University of Bristol investigated whether tocilizumab, an anti-inflammatory drug commonly used for immune conditions such as rheumatoid arthritis, could improve symptoms of difficult-to-treat depression....
Original Source
Read the full article at Theguardian →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.